Filter posts

With an Air of Optimism, #BIOCEO19 Concludes

Despite considerable pressure directed squarely at biotech innovators from politicians of every stripe, biotech executives …

Meet Kallyope’s Nancy Thornberry, Fireside Chat Speaker at #BIOCEO19

Biotech startups come in all shapes, sizes and approaches but have one thing in common: …

Using Decision Science for Negotiations: Getting to Win-Win

New medicines often progress from idea to regulatory approval through collaborative licensing agreements or acquisition.  …

Interactive Map Displays Strength of Industry’s National Footprint

BIO’s biennial economic development and jobs report focuses on the economic progress and national footprint …

BIO Celebrates 300 Biotech IPOs since Enactment of the JOBS Act

The biotech industry recently realized its 300th IPO since the Jumpstart Our Business Startups (JOBS) …

New Member Benefit: Online Marketplace for Custom Scientific Research Services and Products

BIO’s member companies in the pharmaceutical, life sciences, chemicals, and biotechnology sectors routinely and strategically …

#MakeHistory: Highlighting History I China

Venture capital investment in US biotech companies has skyrocketed as Chinese investors continue to fuel …

Director of USPTO Addressed Intellectual Property Track Opening Plenary

This afternoon USPTO Director Andrei Iancu delivered remarks at the BIO International Convention’s Intellectual Property Track …

New Study Shows Strong Interest in China Partnerships

A new report suggests that biopharmaceutical companies are expressing strong interest in the Chinese marketplace. …

Give Your Business Development Skills a Boost Before #BIO2018!

There is no better place to make the connections you need to secure licensing, investment …